| Trial Identifier: | TES16382 |
| Sponsor: | Sanofi |
| Start Date: | October 2022 |
| Primary Completion Date: | August 2023 |
| Study Completion Date: | April 2024 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| BELGIUM | Edegem, BELGIUM, 2650 |
| FRANCE | DIJON, FRANCE, 21079 |
| FRANCE | MARSEILLE, FRANCE, 13385 |
| SPAIN, Catalunya [Cataluña] | Barcelona, Catalunya [Cataluña], SPAIN, 08023 |
| SPAIN, Madrid, Comunidad de | madrid, Madrid, Comunidad de, SPAIN, 28040 |
| Turkey | Ankara, Turkey, 06800 |
| UNITED STATES, Texas | Dallas, Texas, UNITED STATES, 75230 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company